Citation

Mehlman MJ. Milbank Q. 2004; 82(3): 483-506, table of contents.

Affiliation

Law-Medicine Center, Case Western Reserve University School of Law, 11075 East Boulevard, Cleveland, OH 44106, USA. mjm10@case.edu

Copyright

(Copyright © 2004, Milbank Memorial Fund, Publisher John Wiley and Sons)

DOI

10.1111/j.0887-378X.2004.00319.x

PMID

15330974

PMCID

PMC2690227

Abstract

New drugs that enhance cognition in cognitively healthy individuals present difficult public policy challenges. While their use is not inherently unethical, steps must be taken to ensure that they are safe, that they are widely available to promote equality of opportunity, and that individuals are free to decide whether or not to use them.

Language: en